1,370 Elevance Health, Inc. $ELV Shares Purchased by Krilogy Financial LLC

Krilogy Financial LLC boosted its stake in Elevance Health, Inc. (NYSE:ELV) by 79.9% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 3,085 shares of the company’s stock after buying an additional 1,370 shares during the period. Krilogy Financial LLC’s holdings in Elevance Health were worth $1,302,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of ELV. Kilter Group LLC acquired a new position in Elevance Health in the second quarter valued at about $28,000. WealthCollab LLC increased its position in shares of Elevance Health by 42.2% during the first quarter. WealthCollab LLC now owns 91 shares of the company’s stock valued at $27,000 after acquiring an additional 27 shares during the last quarter. Elevation Wealth Partners LLC increased its position in shares of Elevance Health by 600.0% during the second quarter. Elevation Wealth Partners LLC now owns 105 shares of the company’s stock valued at $41,000 after acquiring an additional 90 shares during the last quarter. Tacita Capital Inc acquired a new stake in shares of Elevance Health during the second quarter valued at about $44,000. Finally, Danske Bank A S purchased a new stake in shares of Elevance Health in the 2nd quarter valued at approximately $44,000. 89.24% of the stock is currently owned by hedge funds and other institutional investors.

Elevance Health Price Performance

ELV stock opened at $429.13 on Friday. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.52 and a quick ratio of 1.52. The firm has a market capitalization of $93.06 billion, a P/E ratio of 19.07, a P/E/G ratio of 2.22 and a beta of 0.70. The business’s 50-day moving average is $403.50 and its two-hundred day moving average is $385.61. Elevance Health, Inc. has a 1 year low of $274.84 and a 1 year high of $436.24.

Elevance Health (NYSE:ELV) last announced its quarterly earnings data on Wednesday, July 15th. The company reported $7.45 EPS for the quarter, topping analysts’ consensus estimates of $6.21 by $1.24. Elevance Health had a return on equity of 14.64% and a net margin of 2.47%. The business had revenue of $49.83 billion during the quarter, compared to the consensus estimate of $48.88 billion. During the same period in the previous year, the company posted $8.84 earnings per share. The business’s revenue for the quarter was up .8% on a year-over-year basis. Analysts anticipate that Elevance Health, Inc. will post 27.22 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

ELV has been the topic of several recent analyst reports. Weiss Ratings restated a “hold (c)” rating on shares of Elevance Health in a report on Thursday, August 13th. Wall Street Zen cut shares of Elevance Health from a “buy” rating to a “hold” rating in a research report on Sunday, July 12th. Truist Financial lifted their target price on shares of Elevance Health from $450.00 to $475.00 and gave the company a “buy” rating in a report on Tuesday, July 14th. The Goldman Sachs Group reiterated a “neutral” rating and issued a $395.00 target price on shares of Elevance Health in a report on Thursday, July 16th. Finally, Guggenheim boosted their target price on Elevance Health from $455.00 to $460.00 and gave the company a “buy” rating in a research report on Monday. Fifteen investment analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $441.71.

Elevance Health Profile

Elevance Health, Inc (NYSE: ELV) is a health benefits and services company that provides health insurance, managed care and related healthcare solutions in the United States. Its offerings serve individuals, employers, government-sponsored programs and other organizations across commercial, Medicare and Medicaid markets.

The company operates a portfolio of health plans, including Blue Cross Blue Shield-affiliated plans in several states, as well as government-focused plans marketed under brands such as Wellpoint.